4Sc AG logo

VSC - 4Sc AG News Story

€1.4 -0.3  -18.4%

Last Trade - 07/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £61.4m
Enterprise Value £31.3m
Revenue £1.96m
Position in Universe 794th / 1050

BRIEF-4SC And Netherlands Cancer Institute Work On Evaluation Of Domatinostat

Wed 16th October, 2019 6:35am
Oct 16 (Reuters) - 4SC AG  VSCk.DE :
    * 4SC AND NETHERLANDS CANCER INSTITUTE COLLABORATE ON
CLINICAL
EVALUATION OF DOMATINOSTAT IN THE NEOADJUVANT SETTING IN
MELANOMA
    * PHASE IB STUDY TO START IN Q4, 2019

Source text for Eikon:  ID:nEQ1l773da 
Further company coverage:  VSCk.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.